期刊文献+

304例重度子痫前期患者终止妊娠时机和妊娠结局分析 被引量:7

Time and method of pregnancy termination in severe preeclampsia and the pregnancy outcome
下载PDF
导出
摘要 目的分析重度子痫前期的并发症及其妊娠结局,寻求终止妊娠最佳时机和方式。方法对304例重度子痫前期患者进行回顾性分析,比较不同孕周及分娩方式与母婴预后的关系。结果 304例重度子痫前期合并肝功能异常、肾功能异常、重度贫血、低蛋白血症、高血压性心脏病、胎盘早剥、HELLP综合征、DIC及产后出血等275例,其发生率为90.5%。不同孕周分娩方式均以剖宫产为主(79.6%),孕<34周组经阴道分娩相对较多,其中有12例为引产;而≥34孕周组剖宫产率较高,但与前者比较差异无统计学意义(P>0.05)。新生儿窒息发生率为11.8%(36/304),围产儿死亡率为8.9%(27/304),三组新生儿窒息率和围产儿死亡率比较差异有统计学意义;孕<34周分娩组新生儿窒息率和围生儿死亡率最高(P<0.05)。重度子痫前期在37周孕周前终止妊娠者,其胎盘早剥、胎儿宫内窘迫的发生率明显高于≥37孕周终止妊娠者。304例患者经治疗后痊愈出院,无孕产妇死亡。结论重度子痫前期并发症随着孕周增加而增多,适时终止妊娠可减少母婴并发症,降低围产儿死亡。孕34周以后在促胎肺成熟后择期剖宫产;病情特别严重者,剖宫产分娩时机可提前到孕32周以前甚至剖宫取胚。足月者胎儿宫颈成熟,病情允许的情况下可以经阴道分娩。 Objective To study the relationship between the time and method of pregnancy termination and the pregnancy outcome.Methods 304 pregnant women suffered from severe preeclampsia were enrolled for study.The outcome of mothers and new borns including the rates of neonatal asphyxia,perinatal mortality were observed.Results There was no maternal death.The cesarean section rate was 79.6%.Neonatal asphyxia rate was 11.8%,The perinatal mortality rate was 8.9%.Conclusion In severe preeclampsia,pregnancy should be terminated in time,pregnancy terminated is one of the most important treatment methods,and cesarean section is the first choice.
出处 《四川医学》 CAS 2012年第7期1147-1149,共3页 Sichuan Medical Journal
关键词 妊娠 重度子痫前期 并发症 妊娠结局 pregnancy preeclampsia complications pregnancy outcome
  • 相关文献

参考文献4

二级参考文献14

  • 1杨孜,李蓉,石凌懿,王丽娜,叶蓉华,王荣,黄萍.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40(5):302-305. 被引量:333
  • 2杨孜,王伽略,黄萍,石凌懿,李蓉,叶蓉华,陈蕾.重度子癎前期终末器官受累不平行性及其围产结局探讨[J].中华围产医学杂志,2006,9(1):10-14. 被引量:109
  • 3Genbacev O,Zhou Y,Ludlow JW,et al.Regulation of human placental development by oxygen tension.Science,1997,277(5332):1669-1672
  • 4Barber A,Robson SC,Myatt L,et al.Heme oxygenase expression in human placenta and placental bed:reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction.FASEB J,2001,15(7):1158-1168
  • 5Many A,Hubel CA,Fisher SJ,et al.Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.Am J Pathol,2000,156(1):321-331
  • 6ACOG Committee on Practice Bulletins-Obstetrics.ACOG practice bulletin.Diagnosis and management of preeclampsia and eclampsia.American college of obstetricians and gynecologists Number 33,Obstet Gynecol,2002,99:159-167.
  • 7Gary C,Norman FG,Kenneth JL,et al.Hypertensive disorders of pregnancy.In:Cunningham FG,Gant NF,Leveno KJ,eds.Williams Obstetrics.21st ed.New York:McGraw-Hill,2002.569-619.
  • 8Sibai BM.The HELLP syndrome:much ado about nothing? Am J Obestet Gynecol,1990,162:311-316.
  • 9Sibai BM,Abdella TN,Spinnato JA,et al.Eclampsia V.The incidence of nonpreventable eclampsia.Am J Obstet Gynecol,1986,154:581.
  • 10Buchbinder A,Sibai BM,Caritis S,et al.Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.Am J Obstet Gynecol,2002,186:66-71.

共引文献223

同被引文献66

  • 1王敏,郭丽.卵巢癌患者体内可溶型Fas水平测定及其免疫诊断学意义[J].中华医学研究与实践,2004,2(5):4-5. 被引量:1
  • 2杨孜,郭艳军.早期早产的研究进展[J].实用妇产科杂志,2005,21(11):652-654. 被引量:28
  • 3胡继芬,陈丽红,李云,游彩玲.重度子癎前期终止妊娠时间对母儿预后的影响[J].中国实用妇科与产科杂志,2006,22(7):522-524. 被引量:5
  • 4Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocel: lular carcinoma patients induces CIM CD25 Foxp3 T cells [ J ]. Gastroenterology, 2008,135 ( 1 ) :234-243.
  • 5Lesokhin AM, Hohl TM, Kitano S, et al. MonoeyticCCR2 myeloid- derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment [ J]. Cancer Res,2012,72(4) :876-886.
  • 6Yokoyama I, Waxman F. Differential susceptibility of immunecomp- lexs to release from the erythrocyte CR, receptor by factort [J ]. Mol Immunol, 1994,31 (4) :227.
  • 7Chang B, Liu G, Yang G, et al. REDD1 is required tbr RAS. media ted transformation of human ovarian epithelial cells [ J ]. Cell Cycle ,2009,8 (5) :780-786.
  • 8Kottakis F, Polytarchou C, Foltopoulou P, et al. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/ KDM2B-mir-101 -EZH2 pathway [ J ]. Molecular Cell, 2011,43 : 285 -298.
  • 9Sharon EJ, Jonathan B, Chen XQ, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the Ovarian Cancer Association consortium [ J ] Twin Res Hum Genet ,2009,12 ( 3 ) :269-275.
  • 10Pouzo MG, Lesurf R, Petkiewicz S, et al. Met induces mammary tunor8 with diverse histologies and. is associated with poor outcome andhuman basal breast cancer [ J ]. Pmc Natl Acad Sci USA,2009,106(31 ) :12903-12908.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部